REVA Medical  a San Diego  California firm  landed the European CE Mark for its first product  the drug-eluting bioresorbable Fantom coronary scaffold The device contains sirolimus  aka rapamycin  an immunosuppressant to help prevent restenosis  which is delivered to the implantation area slowly over time